Global Animal Model Market Size study & Forecast, by Animal Type (Mice, Birds, Fish, Cattle, Other Animal Types), by Technology (CRISPR, Embryonic Stem Cell Injection, Nuclear Transfer, Other Technologies), by Application (Oncology, Cardiovascular, Neurol

Global Animal Model Market Size study & Forecast, by Animal Type (Mice, Birds, Fish, Cattle, Other Animal Types), by Technology (CRISPR, Embryonic Stem Cell Injection, Nuclear Transfer, Other Technologies), by Application (Oncology, Cardiovascular, Neurology, Other Applications), and Regional Analysis, 2023-2030

Global Animal Model Market is valued approximately at USD XX billion in 2022 and is anticipated to grow with a growth rate of more than 8.6% over the forecast period 2023-2030. An animal model refers to a living organism, typically an animal, used in scientific research to simulate and study biological and pathological processes, as well as to understand and investigate various aspects of human health and disease. Animal models serve as experimental systems that mimic certain aspects of human physiology, anatomy, genetics, and behavior, allowing scientists to observe and manipulate these systems in controlled laboratory settings. Animal models are employed across various disciplines, including biomedical research, drug development, genetics, toxicology, and behavioral studies, to gain insights into fundamental biological processes, test hypotheses, evaluate treatments, and advance scientific knowledge. The Animal Model Market is growing because of factors such as increasing preclinical trials, increasing adoption of CRISPR technology and growing investments in R&D of pharmaceutical industry.

According to Statista, globally, the R&D spending in the pharmaceutical industry reached approximately USD 238 billion in 2021. The growing rate of preclinical trials is also helping in driving the market growth. According to the World Health Organization (WHO) report in February 2022, there were 47,689 registered preclinical trial studies conducted in 2021. This significant increase in the number of preclinical studies indicates a growing demand for animal models in research. Moreover, advancements in genetic engineering and genome editing techniques may create lucrative opportunities for the market. However, high research cost and growing criticism on animal testing by several organizations stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Animal Model Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 with largest market share owing to factors such as the presence of key industry players, increasing biomedical research in the United States, and the growing preclinical activities conducted by clinical research organizations (CROs) and pharmaceutical companies in the region. However, Asia Pacific is expected to grow significantly during the forecast period, owing to increase in the government initiatives and investments in drug research utilizing animal models, the growing significance of mouse clinical trials (MCTs) for improved outcome projections, ongoing innovations in animal models, the availability of advanced healthcare systems, and a substantial surge in demand for advanced healthcare facilities.

Major market player included in this report are:
Biocytogen Pharmaceuticals Co. Ltd
Labcorp UK Limited (Envigo Rms Inc.)
Hera Testing Laboratories
Charles River Laboratories International Inc.
The Jackson Laboratory
Harbour BioMed Co. Ltd
PerkinElmer Inc. (Horizon Discovery Group PLC)
Janvier Labs
Trans Genic Inc.
Taconic Biosciences Inc.

Recent Developments in the Market:
In June 2023, Charles River Laboratories International, Inc. and Curigin, a Korean biotechnology company specializing in the development of innovative oncolytic ribonucleic acid interference (RNAi) gene therapies, announced a collaborative partnership. The collaboration aims to focus on adenoviral vector production, a critical component in the development of gene therapies.
In May 2023, Biocytogen Pharmaceuticals Co., Ltd. has announced their expansion in San Francisco, California, USA. The newly established space will help in facilitating the global expansion of Biocytogen's businesses.
In March 2023, Biocytogen Pharmaceuticals Co., Ltd. and Janssen Biotech, Inc., a subsidiary of Johnson & Johnson's Janssen Pharmaceutical Companies, have entered into a non-exclusive license agreement. The agreement was facilitated by Johnson & Johnson Innovation LLC.

Global Animal Model Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered – Animal, Technology, Application, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Animal Type:
Mice
Birds
Fish
Cattle
Other Animal Types

By Technology:
CRISPR
Embryonic Stem Cell Injection
Nuclear Transfer
Other Technologies

By Application:
Oncology
Cardiovascular
Neurology
Other Applications

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Companies Mentioned
Biocytogen Pharmaceuticals Co. Ltd
Labcorp UK Limited (Envigo Rms Inc.)
Hera Testing Laboratories
Charles River Laboratories International Inc.
The Jackson Laboratory
Harbour BioMed Co. Ltd
PerkinElmer Inc. (Horizon Discovery Group PLC)
Janvier Labs
Trans Genic Inc.
Taconic Biosciences Inc.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.